Our FANTOM program is dedicated to spreading the fruits of our research far and wide. Early career researchers will engage in diverse outreach activities, including collaborative efforts with the ‘Naked Scientists’ and ‘Open Science,’ providing them with comprehensive training in communication skills. They’ll participate in science festivals, like the Cambridge University Science Festival, where they’ll lead engaging activities to demystify topics such as immune system cancers. Through social media, particularly Twitter, and interactions with the press, they’ll share their findings with both professional and lay audiences. All dissemination efforts will recognize the support received from the European Union’s Horizon 2021 Marie Skłodowska-Curie Doctoral Training Networks.
Rebekka Johanna Sabine Salzmann (UNIPD) about her research in podcast series
My research focuses on why patients with the same type of cancer can respond very differently to the same treatment. One key reason appears to be the body’s own defense system
Aiindrila Dhara (MUNI) about her research in podcast series
My PhD research focuses on understanding how cancer cells evolve during treatment, particularly how they become resistant to targeted therapies over time. I study a type of childhood cancer called ALK-positive Anaplastic Large Cell Lymphoma
Will Shepheard – Secondment at the Technical University of Munich (TUM)
Working in Professor Lena Illert’s laboratory and closely alongside Magdalena, I worked with clinical ALK+ ALCL patient samples using the PhenoCycler-Fusion 2.0 system (Akoya Biosciences).
Carla Vázquez Amos (UCAM – Fantom´s UKRI associate) – PODcast session
My research focuses on understanding how and why people get cancer. Specifically, I study two subtypes of a rare immune cell cancer called Anaplastic Large Cell Lymphoma (ALCL). In this disease, T cells that are usually protecting the body
Aiindrila Dhara – Secondment at the University of Cambridge
This experience has been incredibly valuable both scientifically and professionally. During my time at Suzanne Turner’s Lab in the Department of Pathology, University of Cambridge, I had the opportunity to work closely
Nicola Mora (MUW) about his research in podcast series
My research is about a cancer called ALCL, which affects immune cells known as T-cells. These cells normally help your body fight infections, but in this disease they accumulate genetic errors and start multiplying uncontrollably